Promacta for low platelets approved by FDA
At last the second drug for low platelets - Eltrombopag/Promacta/Revolade has been approved by FDA for patients with Immune Thrombocytopenic Purpura!
We hope that the trials with treatment with Promacta for low platelets due to treatment of Hepatitis C and cancer like sarcoma will show good effect and that patients with bone marrow diseases can tolerate the drug.
Manufacturer's Promacta prescription information (PDF, 371K).
|All times are GMT -4. The time now is 01:11 PM.|
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2021, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org